|
|
-
BioTime’s Unit Cell Cure Neurosciences Ltd. Gets $1.5 Mln Grant From Israel’s Office Of The Chief Scientist
5/13/2013
|
|
|
-
Alexza Pharma To Discuss Agreement With Teva To Market ADASUVE In U.S.
5/8/2013
|
-
Teva Pharmaceuticals USA, Alexza Enter Into Exclusive U.S. License And Supply Agreement For ADASUVE
5/8/2013
|
-
OncoGenex Pharma Q1 Loss/Share Narrows To $0.46 From $0.67 Last Year; Provides Clinical Development Program Overview
5/2/2013
|
|
|
|
|
-
Teva Pharmaceutical Industries Posts Q1 EPS Of $0.74 Vs. $0.97 Last Year
5/2/2013
|
|
|